Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' reply.
Vivek Chand GoodooryCho Ee NgChristopher J BlackAlexander Charles FordPublished in: Alimentary pharmacology & therapeutics (2022)